Where fat sits is largely genetic. Nonsurgical fat reduction lowers the number of fat cells in one pinchable pocket.
Book a consultationFat, or skin?
Nonsurgical fat reduction here means injectable deoxycholic acid. Kybella® is FDA-approved for the improvement in appearance of moderate to severe fullness under the chin in adults, and most patients need 2 to 4 sessions. It is not weight loss, and it does not tighten skin.
Most people want one thing: a softer shadow. It lowers the number of fat cells in one pocket of subcutaneous fat, the layer you can pinch.
Kybella® is deoxycholic acid, a bile acid your body already makes. Injected on a 1 cm grid, it breaks fat-cell membranes. Clearance is the slow step. Kybella® is FDA-approved for the improvement in appearance of moderate to severe fullness under the chin in adults, so injection anywhere else on the body is off-label use, meaning the FDA has not reviewed that particular use.
| Option | What is used | Regulatory status | Typical sessions | Downtime | What it does not do |
|---|---|---|---|---|---|
| Kybella® | Deoxycholic acid, injected in a grid across the fat pad | FDA-approved for the improvement in appearance of moderate to severe fullness under the chin in adults; other areas are off-label | 2 to 4, at least 4 weeks apart | Marked swelling 5 to 14 days, longest after the first session; numbness can last weeks | Tighten skin, add chin projection, or treat neck bands |
| Chin filler, for comparison | Hyaluronic acid gel placed against the bone | Specific hyaluronic acid products are FDA-approved for chin augmentation | 1, with a review at two weeks | Bruising 3 to 7 days | Reduce fat. It changes the outline the fat sits against |
| Neuromodulator to the neck, for comparison | Purified botulinum toxin into the platysma | One botulinum toxin product is FDA-approved for moderate to severe platysma prominence in adults; other neck and lower-face uses are off-label | 1, repeated every 3 to 4 months | Little to none | Reduce fat or change skin quality |
These options behave differently. What decides is what the fullness is made of: fat, bone, muscle or skin. Ranges come from product labeling, device clearance and observation here.
Kybella® — Deoxycholic acid. FDA-approved for moderate to severe convexity or fullness associated with submental fat in adults; the label permits up to six treatments, at least one month apart. Injection anywhere else on the body is an off-label use, which means the FDA has not reviewed that particular use: the drug is the same, the indication has not been through approval.
Deoxycholic acid — A bile acid the body already makes to break down dietary fat. It disrupts fat-cell membranes on contact and is not selective about which cells it reaches, which is why the depth and placement of each injection decide the result more than the volume given.
Topical and injected local anesthetic — Lidocaine, with or without epinephrine, plus ice. Comfort during a Kybella® session comes from a combination rather than a single agent, because the burning is produced by the drug acting on the fat and not by the needle.
Compounded lipolytic injections — Phosphatidylcholine and similar compounded fat-dissolving mixtures are not FDA-approved for fat reduction, and are not used here.
Your provider pinches the area, tests recoil, and separates fat from gland, muscle and laxity.
The number of sessions, the interval and the total range are written down first.
The area is marked with you upright, because fat shifts when you lie down.
At four to six weeks, photographed and compared with your first set.
Expect 5 to 10 minutes of burning, then a dull ache. Plan around the swelling, not the appointment.
Nothing shows on day ten. Most patients need two to four sessions, with change visible after the second. Treated cells do not return.
No. Liposuction removes fat through a cannula under anesthesia, addressing a larger volume in one session. Kybella® destroys fat cells where they sit and lets your body clear them over weeks, with no incision.
Kybella® is measured in sessions rather than percentages. Most patients need two to four before the change is obvious in photographs, and each session is decided at the review.
You usually cannot tell by looking. A low-lying submandibular gland, a prominent digastric muscle, or skin that has lost recoil produce the same profile as fat. A pinch, a swallow and a recoil test separate them.
Plan on three to six months for a course rather than a single visit. Sessions sit at least four weeks apart, because that window is when your body clears the treated cells.
No. Under the chin is the only approved area, and it works on a defined pocket you can pinch at a stable weight. It does not reach visceral fat, or treat obesity, laxity, diastasis or a hernia. The abdomen usually presents with a mix of those.
Not yet, and that is timing rather than a refusal. Fat reduction is contouring for a pocket that persists at a stable weight. Treating before a planned loss can mean paying for fat the loss would have taken.
No. Kybella® does not act on skin, and reducing the fat underneath can make laxity more visible. Skin recoil is tested by pinching and releasing. Where recoil is poor, the approaches that address skin are surgical.
The serious risks are uncommon. Kybella® off-target can injure the marginal mandibular nerve, showing as an uneven smile, usually temporary. Into gland, muscle or skin, it can cause ulceration. Difficulty swallowing has also been reported.
Treatment costs vary with the plan. Contact the practice for current pricing, what is included, and any applicable booking terms.
Kybella® is the only option here, and it is numbed first: 5 to 10 minutes of burning, then a dull ache. You can work the same day, though swelling shows 5 to 14 days.
Kybella® is FDA-approved for moderate to severe convexity or fullness associated with submental fat in adults. Use in any other area of the body is off-label. Off-label use is legal and common in medicine, and we name it before you consent.
Fat reduction is body contouring, not weight loss, and it is not a treatment for obesity. Individual results vary, and nothing on this page is a promise of a specific result.
They record one patient's outcome and do not predict yours.
This page is general information, not medical advice. Kybella® is a prescription medicine, and it requires an in-person assessment before treatment.
Kybella® is a registered trademark of Allergan, Inc., an AbbVie company. Rouge Aesthetics is an independent practice, not affiliated with, sponsored by or endorsed by any of them, and names them only to identify products used here.
Rouge Aesthetics · 101 Mill Street, Suite 210, Gahanna, OH 43230 · (614) 425-1633
Individual results vary. This website provides general information and does not replace an individual consultation.